BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Breaking News: BioWorld Science 2025 Year in Review
Breaking News: BioWorld 2025 Year in Review
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science
BioWorld Science
RSS
Yamanouchi reports on GI drugs in development
Oct. 11, 1996
Gastrointestinal drugs in the pipeline at Fujisawa
Oct. 11, 1996
Axcan acquires enzyme preparation for pancreatic insufficiency
Oct. 11, 1996
Promising results from U.S. trial on Zadaxin for hepatitis C
Oct. 11, 1996
New hepatoprotectants from Nisshin Flour Milling
Oct. 11, 1996
Medeva acquires rights to nicotine for ulcerative colitis
Oct. 11, 1996
European approvals for Zantac
Oct. 11, 1996
Zenyaku Kogyo discloses anti-Helicobacter pylori agents
Oct. 11, 1996
Renal-urologic drugs in development at Yamanouchi
Oct. 11, 1996
Three renal-urologic drugs reported in the Fujisawa product pipeline
Oct. 11, 1996
Previous
1
2
…
17669
17670
17671
17672
17673
17674
17675
17676
17677
…
17987
17988
Next